Frequency of the CHEK2 1100delC mutation among women with breast cancer: An international study

Cancer Research

Volumn 68, Issue 7, 2008, Pages 2154-2157

  Zhang, Shiyu ^a   Phelan, Catherine M ^d   Zhang, Phil ^a   Rousseau, Francois ^e   Ghadirian, Parviz ^f   Robidoux, Andre ^f   Foulkes, William ^g   Hamel, Nancy ^g   McCready, David ^b   Trudeau, Maureen ^c   Lynch, Henry ^h   Horsman, Douglas ⁱ   De Matsuda, Maria Lourdes Leon ^j   Aziz, Zeba ^k   Gomes, Magda ^l   Costa, Mauricio Magalhaes ^m   Liede, Alexander ⁿ   Poll, Aletta ^a   Sun, Ping ^a   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITÉ LAVAL   (Canada)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g MCGILL UNIVERSITY   (Canada)

^h CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j PHILIPPINE GENERAL HOSPITAL   (Philippines)

^k ALLAMA IQBAL MEDICAL COLLEGE   (Pakistan)

^l FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^m FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁿ AMGEN INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; MUTATION; NORTH AMERICA; PROTEIN-SERINE-THREONINE KINASES;

EID: 42049120693     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5187     Document Type: Article

References (16)

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
3. Meijers-Heijboer H, van den Ouweland A, Klijn J, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002;31:55-9.
4. CHEK2 Breast Cancer Case-Control Consortium. CHEK2* 1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from10 studies.Am J Hum Genet 2004;4:1175-82.
5. Vahteristo P, Bartkova J, Eerola H, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002;71:432-8.
6. Cybulski C, Gorski B, Huzarski T, et al. CHEK2 is a multi-organ cancer susceptibility gene. Am J Hum Genet 2004;75:1131-5.
7. Osorio A, Rodriguez-Lopez R, Diez O, et al. The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 2004;108:54-6.
8. Giroux S, Dube-Linteau A, Cardinal G, et al. Assessment of the prevalence of the 985A>G MCAD mutation in the French-Canadian population using allele-specific PCR. Clin Genet 2007;71:569-75.
9. Schutte M, Seal S, Barfoot R, et al. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am J Hum Genet 2003;72:1023-8.
10. Kuschel B, Auranen A, Gregory CS, et al. Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:809-12.
11. Offit K, Pierce H, Kirchhoff T, et al. Frequency of CHEK2*1100 delC in New York breast cancer patients. BMC Med Genet 2003;4:1.
12. Cybulski C, Wokoloroczyk D, Huzarski T, et al. A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treatment 2007;102:119-22.
13. Shaag A, Walsh T, Renbaum P, et al. Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. Hum Mol Genet 2005;14:555-63.
14. Cybulski C, Gliniewicz B, Sikorski A, et al. Epistatic relationship between the cancer susceptibility genes CHEK2 and p27. Cancer Epidemiol Biomarkers Prev 2007;16:572-6.
15. Parkin DM, Whelan SL, Ferlay J, et al., editors. Cancer incidence in five continents. Vol III. Lyon: IARC Scientific Publications; 2002.
16. Narod SA, Lynch HT. CHEK2 mutation and hereditary breast cancer. J Clin Oncol 2007;25:6-7.